AdaptHealth Corp. (NASDAQ:AHCO) finished Wednesday with a subtraction of -$1.33 to close at $20.38, a downside of -6.13 percent. An average of 2,842,340 shares of common stock have been traded in the last five days. There was a gain of $1.40 in the past week, and it reached a new high 14 times over the past 12 months. The last 20 days have seen an average of 1,648,405 shares traded, while the 50-day average volume stands at 2,033,500.
AHCO stock has decreased by -1.69% in the last month. The company shares reached their 1-month lowest point of $16.90 on 09/06/22. With the stock rallying to its 52-week high on 08/03/22, shares of the company touched a low of $11.40 and a high of $28.75 in 52 weeks. It has reached a new high 2 times so far this year and lost -16.68% or -$4.08 in price. In spite of this, the price is down -29.11% from the 52-week high.
China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal
Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.
Simply click here and the name & trading symbol are yours.
22 days have passed since AdaptHealth Corp. (AHCO) last reported insider trading activity. Williams David Solomon III, who is Director, most recently acquired $2,254 shares at $18.19 per share on Aug 31. In this transaction, the insider spent $40,993. General Counsel, JOYCE CHRISTOPHER J, disposed of 100,000 shares at a price of $22.20 on Aug 16. The insider now owns more than $2,219,530 worth of shares. Prior to that, 10% Owner Everest Hill Group Inc. went on to Sale 215,382 shares at $23.50 each on Aug 12. An amount of $5,061,477 was transacted.
AdaptHealth Corp. (AHCO) has a trailing price-to-earnings (P/E) ratio of 22.44. The stock’s beta is 0.55. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 0.93, the price-to-book (PB) ratio at 1.28, and the price-to-cash flow ratio at 132.24.
The quick ratio of AdaptHealth Corp. for the three months ended March 30 was 1.20, and the current ratio was 1.40, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 1.02 and a total debt to equity ratio of 1.03 for the quarter ending March 30. Its gross profit as reported stood at $456.2 million compared to revenue of $2.47 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, AdaptHealth Corp.’s return on assets was 2.40%.
For the three-month period that ended March 30, AdaptHealth Corp. had $2.17 billion in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of $14.03 million in the quarter, while revenues of $41.75 million were shrunk -463.86%. The analyst consensus anticipated AdaptHealth Corp.’s latest quarter earnings to come in at $0.18 per share, but it turned out to be $0.08, a -55.60% surprise. For the quarter, EBITDA amounted to $139.96 million. Shareholders own equity worth $134.5 million.
From a technical analysis perspective, let’s take a brief look at AdaptHealth Corp. (AHCO) price momentum. RSI 9-day as of the close on 21 September was 52.97%, suggesting the stock is Neutral, with historical volatility in this time frame at 74.93%.
As of today, AHCO’s price is $20.70 +7.38% or $1.40 from its 5-day moving average. AHCO is currently trading -1.88% lower than its 20-day SMA and +52.54% higher than its 100-day SMA. However, the stock’s current price level is +5.32% above the SMA50 and +1.90% above the SMA200.
The stochastic %K and %D were 80.90% and 87.27%, respectively, and the average true range (ATR) was 1.14. With the 14-day stochastic at 61.38% and the average true range at 1.07, the RSI (14) stands at 51.54%. The stock has reached 1.25 on the 9-day MACD Oscillator while the 14-day reading was at 1.99.
SVB Leerink launched coverage on AdaptHealth Corp. (NASDAQ: AHCO) in its analyst report released on September 27, 2021. The firm assigned the stock an Outperform rating. The consensus rating for AdaptHealth Corp. (AHCO) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell AHCO, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 1 analysts, while 9 others rate it as a “buy”.
What is AHCO’s price target for the next 12 months?
Analysts predict a range of price targets between $24.00 and $35.00, with a median target of $28.00. Taking a look at these predictions, the average price target given by analysts for AdaptHealth Corp. (AHCO) stock is $28.30.